OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies
Marco Lo Iacono, Soraya Puglisi, Paola Perotti, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5255-5255
Open Access | Times Cited: 22

Showing 22 citing articles:

Therapeutic efficiency of Tamoxifen/Orlistat nanocrystals against solid ehrlich carcinoma via targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 signaling pathways
Thanaa A. El‐Masry, Maysa M. F. El-Nagar, Ghaleb A. Oriquat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117429-117429
Open Access | Times Cited: 7

Sexually dimorphic activation of innate antitumor immunity prevents adrenocortical carcinoma development
James Wilmouth, Julie Olabe, Diana García-García, et al.
Science Advances (2022) Vol. 8, Iss. 41
Open Access | Times Cited: 21

Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
Augustine Jing Jie Koh, Maytham Hussein, Gauri G. Rao, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1420-1420
Open Access | Times Cited: 21

Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells
Aurora Schiavon, L. Saba, Carlotta Evaristo, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117917-117917
Closed Access

Navigating Uncertainty in Adjuvant Mitotane Therapy
Massimo Terzolo, Martin Faßnacht, Alfredo Berruti, et al.
Endocrine Practice (2025)
Closed Access

Adrenal cancer: Current status of preclinical research
S. Sneha Letha, Hemant Kumar Yadav, Soumyabrata Basak, et al.
Elsevier eBooks (2025), pp. 139-176
Closed Access

Human adrenocortical carcinoma cell line (NCI-H295R): An in vitro screening model for the assessment of endocrine disruptors’ actions on steroidogenesis with an emphasis on cell ultrastructural features
Hana Ďúranová, Veronika Fialková, Veronika Válková, et al.
Acta Histochemica (2022) Vol. 124, Iss. 5, pp. 151912-151912
Closed Access | Times Cited: 12

A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma
Fabiano Flauto, Maria Cristina De Martino, Chiara Vitiello, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4061-4061
Open Access | Times Cited: 2

Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C
Jessica J. Miller, Kalvin Kwan, Anaïs Blanchet, et al.
Journal of Inorganic Biochemistry (2023) Vol. 242, pp. 112164-112164
Closed Access | Times Cited: 6

Prediction of anticancer peptides derived from the true lectins of Phoenix dactylifera and their synergetic effect with mitotane
Othman A. Baothman, Ehab M. M. Ali, Salman Hosawi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Safe long-term therapy of Cushing’s syndrome over 37 years with mitotane
Jonas Seibold, Mario Hönemann, Anke Tönjes, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1

Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation
Kalvin Kwan, Omar Castro-Sandoval, N. Benjamin, et al.
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112433-112433
Closed Access | Times Cited: 3

Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients’ Management
Aurora Schiavon, L. Saba, Gianluca Catucci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16701-16701
Open Access | Times Cited: 2

Pregnancy in patients with adrenocortical carcinoma: a case-based discussion
Soraya Puglisi, Vittoria Basile, Paola Sperone, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 24, Iss. 1, pp. 85-96
Closed Access | Times Cited: 3

Development and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples
Anna Sylvia Ferrari Marques, Atecla Nunciata Lopes Alves, Berenice B. Mendonça, et al.
Clinics (2024) Vol. 79, pp. 100470-100470
Open Access

Interplay between Immune Cell Infiltration and Tumor Histological Subtype: A Case of Adrenocortical Cancer
A. V. Bogolyubova, N. V. Pachuashvili, A. V. Tkachuk, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5303-5303
Open Access | Times Cited: 2

Sexually dimorphic activation of innate antitumour immunity prevents adrenocortical carcinoma development
James Wilmouth, Julie Olabe, Diana García-García, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Sarah Allegra, Soraya Puglisi, Chiara Borin, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1873-1873
Open Access | Times Cited: 1

Management of adrenocortical carcinoma after failure of mitotane therapy
Salvatore Grisanti, Valentina Cremaschi, Alfredo Berruti
L Endocrinologo (2023) Vol. 24, Iss. 5, pp. 533-537
Open Access

Page 1

Scroll to top